DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009,789,128 | +5.1% | 8,100,722 | +1.7% | 0.39% | +6.0% |
| Q2 2023 | $1,911,796,080 | -7.1% | 7,965,817 | -2.4% | 0.37% | -10.0% |
| Q1 2023 | $2,056,992,451 | -3.4% | 8,161,373 | +1.7% | 0.41% | -8.7% |
| Q4 2022 | $2,129,549,064 | +2.8% | 8,023,318 | +0.0% | 0.45% | -5.5% |
| Q3 2022 | $2,072,339,000 | +1.4% | 8,023,299 | -0.5% | 0.47% | +8.0% |
| Q2 2022 | $2,043,836,000 | -12.9% | 8,061,833 | +0.8% | 0.44% | +6.1% |
| Q1 2022 | $2,345,469,000 | -12.7% | 7,996,009 | -2.1% | 0.41% | -6.1% |
| Q4 2021 | $2,686,782,000 | +7.1% | 8,166,258 | -0.9% | 0.44% | -0.9% |
| Q3 2021 | $2,508,292,000 | +14.2% | 8,239,032 | +0.7% | 0.44% | +14.7% |
| Q2 2021 | $2,196,697,000 | +18.1% | 8,185,631 | -1.0% | 0.39% | +11.8% |
| Q1 2021 | $1,860,127,000 | +0.3% | 8,264,294 | -1.0% | 0.35% | -4.2% |
| Q4 2020 | $1,854,457,000 | +0.7% | 8,348,147 | -2.4% | 0.36% | -10.6% |
| Q3 2020 | $1,841,762,000 | +21.1% | 8,553,203 | -0.5% | 0.40% | +12.2% |
| Q2 2020 | $1,520,566,000 | +26.4% | 8,599,028 | -1.1% | 0.36% | +4.3% |
| Q1 2020 | $1,202,846,000 | -11.4% | 8,690,456 | -1.8% | 0.34% | +13.5% |
| Q4 2019 | $1,357,934,000 | +5.8% | 8,847,622 | -0.5% | 0.30% | -1.0% |
| Q3 2019 | $1,284,051,000 | +0.6% | 8,890,473 | -0.4% | 0.31% | +1.3% |
| Q2 2019 | $1,276,194,000 | +8.8% | 8,929,430 | +0.5% | 0.30% | +4.5% |
| Q1 2019 | $1,173,352,000 | +28.5% | 8,887,690 | +0.4% | 0.29% | +13.3% |
| Q4 2018 | $912,986,000 | -5.5% | 8,853,625 | -0.4% | 0.26% | +8.5% |
| Q3 2018 | $966,044,000 | +9.2% | 8,890,522 | -0.8% | 0.24% | +4.9% |
| Q2 2018 | $884,347,000 | -0.8% | 8,961,768 | -1.5% | 0.22% | -3.0% |
| Q1 2018 | $891,182,000 | +4.4% | 9,102,054 | -1.0% | 0.23% | +7.4% |
| Q4 2017 | $853,753,000 | +6.3% | 9,197,941 | -1.8% | 0.22% | +3.3% |
| Q3 2017 | $803,291,000 | +5.8% | 9,364,554 | +4.1% | 0.21% | -1.4% |
| Q2 2017 | $759,303,000 | -2.6% | 8,997,551 | -1.3% | 0.21% | -5.8% |
| Q1 2017 | $779,763,000 | +13.1% | 9,116,832 | +3.0% | 0.22% | +6.6% |
| Q4 2016 | $689,307,000 | -2.8% | 8,855,427 | -2.2% | 0.21% | -4.5% |
| Q3 2016 | $709,523,000 | -27.2% | 9,051,189 | -6.1% | 0.22% | -30.1% |
| Q2 2016 | $974,021,000 | +6.0% | 9,643,770 | -0.9% | 0.32% | +3.6% |
| Q1 2016 | $919,251,000 | -4.1% | 9,729,025 | -5.7% | 0.30% | -4.1% |
| Q4 2015 | $958,655,000 | +3.5% | 10,321,432 | -5.1% | 0.32% | +2.9% |
| Q3 2015 | $926,270,000 | -3.1% | 10,870,448 | -2.7% | 0.31% | +7.3% |
| Q2 2015 | $955,732,000 | -4.1% | 11,166,401 | -4.9% | 0.29% | -4.0% |
| Q1 2015 | $996,631,000 | -3.6% | 11,738,879 | -2.7% | 0.30% | -3.8% |
| Q4 2014 | $1,033,819,000 | +12.0% | 12,061,818 | -0.7% | 0.31% | +7.6% |
| Q3 2014 | $923,278,000 | -5.0% | 12,151,601 | -1.6% | 0.29% | -4.3% |
| Q2 2014 | $971,944,000 | +4.7% | 12,345,268 | -0.2% | 0.30% | +3.8% |
| Q1 2014 | $928,197,000 | -4.4% | 12,375,953 | -1.6% | 0.29% | -6.1% |
| Q4 2013 | $971,161,000 | +10.2% | 12,579,816 | -1.1% | 0.31% | +0.3% |
| Q3 2013 | $881,394,000 | +6.1% | 12,714,876 | -3.1% | 0.31% | +3.0% |
| Q2 2013 | $830,438,000 | – | 13,119,100 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |